Mati Gill, AION Labs CEO
October 13, 2021 10:45 AM EDT
Financing
AI

Big Phar­ma com­pa­nies join hands with Ama­zon on new Is­rael-based AI in­cu­ba­tor

Nicole DeFeudis

Editor

What do Mer­ck, Pfiz­er, As­traZeneca and Te­va have in com­mon with Ama­zon? As of Wednes­day, they’re all join­ing forces with the Is­rael Biotech Fund to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Post-Hoc: AI bio needs to heed the over­hyped his­to­ry of CRISPR

FDA ad­comm votes unan­i­mous­ly against Pfiz­er's prostate can­cer drug com­bo

Sanofi makes $470M move for Vig­il's Alzheimer's drug, while an­oth­er as­set re­turns to Am­gen

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times